再生医学：外科医生的视角。
Regenerative medicine: a surgeon's perspective.
机构信息
Hagey Laboratory for Pediatric Regenerative Medicine, Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University, Stanford, CA 94305-5148, USA.
出版信息
J Pediatr Surg. 2010 Jan;45(1):11-7; discussion 17-8. doi: 10.1016/j.jpedsurg.2009.10.004.
Abstract
More than 200 million incisions are made in the world each year on children and adults. They all end up with a scar unless there is an unusual situation where we are operating on an early gestation fetus. The question is, "why do we not regenerate?" and "why do we always heal with either a 'normal amount of scarring' or, approximately 15% of the time, with a pathologic amount of scarring (hypertrophic scar or keloid)?"
摘要
每年全球有超过 2 亿例儿童和成人接受手术切口。除了在妊娠早期为胎儿进行手术的特殊情况外，所有切口最终都会留下疤痕。问题是，“为什么我们不能再生？”以及“为什么我们的愈合总是呈现‘正常量的疤痕’或大约 15%的时间呈现病理性疤痕（增生性疤痕或瘢痕疙瘩）？”
相似文献
1
Regenerative medicine: a surgeon's perspective.再生医学：外科医生的视角。
J Pediatr Surg. 2010 Jan;45(1):11-7; discussion 17-8. doi: 10.1016/j.jpedsurg.2009.10.004.
2
Scar management.瘢痕管理
Nurs Stand. 2003;17(52):39-42. doi: 10.7748/ns2003.09.17.52.39.c3456.
3
Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures.皮肤瘢痕形成：病理生理学、分子机制和瘢痕减少治疗学 第二部分。减少皮肤科手术后瘢痕形成的策略。
J Am Acad Dermatol. 2012 Jan;66(1):13-24; quiz 25-6. doi: 10.1016/j.jaad.2011.08.035.
4
[Scar prophylaxis and treatment].[瘢痕预防与治疗]
Ugeskr Laeger. 2015 Oct 12;177(42):V05150384.
5
Scar contractures, hypertrophic scars, and keloids.瘢痕挛缩、增生性瘢痕和瘢痕疙瘩。
Facial Plast Surg. 2001 Nov;17(4):263-72. doi: 10.1055/s-2001-18827.
6
[Scars management].[瘢痕管理]
Tidsskr Nor Laegeforen. 2004 Feb 19;124(4):531-2; author reply 532.
7
[Keloid and hypertrophic scars].[瘢痕疙瘩和增生性瘢痕]
Tidsskr Nor Laegeforen. 2003 Nov 6;123(21):3033-5.
8
Scar management: prevention and treatment strategies.瘢痕管理：预防与治疗策略
Curr Opin Otolaryngol Head Neck Surg. 2005 Aug;13(4):242-7. doi: 10.1097/01.moo.0000170525.74264.f8.
9
Scar management: keloid, hypertrophic, atrophic, and acne scars.瘢痕管理：瘢痕疙瘩、增生性瘢痕、萎缩性瘢痕和痤疮瘢痕。
Semin Cutan Med Surg. 2002 Mar;21(1):46-75. doi: 10.1016/s1085-5629(02)80719-2.
10
Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.骨髓间充质干细胞通过旁分泌信号传导抑制增生性瘢痕成纤维细胞和瘢痕疙瘩成纤维细胞的增殖和促纤维化表型。
J Dermatol Sci. 2016 Aug;83(2):95-105. doi: 10.1016/j.jdermsci.2016.03.003. Epub 2016 Mar 4.
引用本文的文献
1
Assessment of rhomboid flap scars: A patient reported outcome study. A case series.菱形皮瓣瘢痕评估：一项患者报告结局研究。病例系列。
Ann Med Surg (Lond). 2022 Feb 7;75:103328. doi: 10.1016/j.amsu.2022.103328. eCollection 2022 Mar.
2
The impact of incisional negative pressure wound therapy on scar quality and patient-reported outcomes: A within-patient-controlled, randomised trial.切口负压伤口治疗对疤痕质量和患者报告结局的影响：一项患者内对照、随机试验。
Wound Repair Regen. 2022 Mar;30(2):210-221. doi: 10.1111/wrr.13001. Epub 2022 Feb 21.
3
A systematic review evaluating the influence of incisional Negative Pressure Wound Therapy on scarring.一项系统评价评估切口负压伤口治疗对瘢痕形成的影响。
Wound Repair Regen. 2021 Jan;29(1):8-19. doi: 10.1111/wrr.12858. Epub 2020 Aug 21.
4
The embrace device significantly decreases scarring following scar revision surgery in a randomized controlled trial.环抱器在一项随机对照试验中显著减少了瘢痕修复手术后的瘢痕形成。
Plast Reconstr Surg. 2014 Feb;133(2):398-405. doi: 10.1097/01.prs.0000436526.64046.d0.
本文引用的文献
1
Generation of induced pluripotent stem cells using recombinant proteins.利用重组蛋白生成诱导多能干细胞。
Cell Stem Cell. 2009 May 8;4(5):381-4. doi: 10.1016/j.stem.2009.04.005. Epub 2009 Apr 23.
2
Wound repair and regeneration.伤口修复与再生。
Nature. 2008 May 15;453(7193):314-21. doi: 10.1038/nature07039.
3
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.通过特定因子将成人成纤维细胞诱导为多能干细胞。
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
4
Induced pluripotent stem cell lines derived from human somatic cells.源自人类体细胞的诱导多能干细胞系。
Science. 2007 Dec 21;318(5858):1917-20. doi: 10.1126/science.1151526. Epub 2007 Nov 20.
5
Hypertrophic scar formation following burns and trauma: new approaches to treatment.烧伤和创伤后增生性瘢痕的形成：新的治疗方法
PLoS Med. 2007 Sep;4(9):e234. doi: 10.1371/journal.pmed.0040234.
6
Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation.头蛋白抑制可增强体外成骨作用并加速体内骨形成。
J Biol Chem. 2007 Sep 7;282(36):26450-9. doi: 10.1074/jbc.M703282200. Epub 2007 Jul 2.
7
Decoding global gene expression programs in liver cancer by noninvasive imaging.通过非侵入性成像解码肝癌中的全局基因表达程序
Nat Biotechnol. 2007 Jun;25(6):675-80. doi: 10.1038/nbt1306. Epub 2007 May 21.
8
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis.机械负荷通过减少细胞凋亡引发肥厚性瘢痕形成。
FASEB J. 2007 Oct;21(12):3250-61. doi: 10.1096/fj.07-8218com. Epub 2007 May 15.
9
Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice.条件性 GSK-3β 小鼠腭裂和中线缺陷的化学拯救
Nature. 2007 Mar 1;446(7131):79-82. doi: 10.1038/nature05557. Epub 2007 Feb 11.
10
FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state.成纤维细胞生长因子-2抑制小鼠脂肪组织来源的基质细胞的成骨作用，并维持其增殖和成骨潜能状态。
Tissue Eng. 2006 Jun;12(6):1405-18. doi: 10.1089/ten.2006.12.1405.
Zotero 插件